Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ASD | Ann: ASD NTA 18-03-2024 $1.77562 | 08:03 | 0 | 19 | |||
|
|||||||
ASD | Ann: ASD NTA 15-03-2024 $1.76823 | 18/03/24 | 0 | 23 | |||
|
|||||||
ASD | Ann: ASD NTA 14-03-2024 $1.77402 | 15/03/24 | 0 | 34 | |||
|
|||||||
ASD | Ann: ASD NTA 13-03-2024 $1.77958 | 14/03/24 | 0 | 35 | |||
|
|||||||
ASD | Ann: ASD NTA 12-03-2024 $1.76924 | 13/03/24 | 0 | 34 | |||
|
|||||||
ASD | Ann: ASD NTA 11-03-2024 $1.77374 | 12/03/24 | 0 | 28 | |||
|
|||||||
ASD | Ann: ASD NTA 08-03-2024 $1.81241 | 11/03/24 | 0 | 58 | |||
|
|||||||
ASD | Ann: ASD NTA 07-03-2024 $1.79078 | 08/03/24 | 0 | 40 | |||
|
See All Discussions